Leerink Partners Remains Bullish on Alnylam Pharma (ALNY) Ahead of ALN-PCSsc Ph I data

Go back to Leerink Partners Remains Bullish on Alnylam Pharma (ALNY) Ahead of ALN-PCSsc Ph I data
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Delayed: 288.18 +1.77 (0.62%)
Previous Close $286.41    52 Week High $109.10 
Open $290.89    52 Week Low $31.38 
Day High $291.95    P/E N/A 
Day Low $285.26    EPS $-1.45 
Volume 1,087,497